Serum asymmetric dimethylarginine and ni
✍
Hikmet Kocak; Yıldız Oner-Iyidogan; Figen Gurdol; Pernur Oner; Deniz Esin
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 184 KB
Background: It has been reported that estrogen deficiency after menopause might cause a decrement in nitric oxide (NO) bioavailability by increasing the level of asymmetric dimethylarginine (ADMA), a major endogenous nitric oxide synthase inhibitor, thus leading to abnormalities in endothelial funct